FDA Launches Real-Time Clinical Trials Pilot With AstraZeneca and Amgen, Aiming to End Years-Long Reporting Lags
The FDA announced two proof-of-concept real-time cancer trials and opened public comment on a broader pilot program, betting that cloud and AI-mediated data flow can compress drug review timelines.
5 min read3 sources